Knopp Biosciences to Present at Piper Jaffray 31st Annual Healthcare Conference
Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for immunological and neurological diseases of high unmet need, today announced that management will present at the Piper Jaffray 31st Annual Healthcare Conference to be held in New York, NY on December 3-5.
Michael Bozik, M.D., President and CEO of Knopp Biosciences, is scheduled to present on Tuesday, December 3rd at 8:10 a.m. Eastern Time.
ABOUT KNOPP BIOSCIENCES LLC
Knopp Biosciences is a privately held drug discovery and development company focused on delivering breakthrough treatments for immunological and neurological diseases of high unmet need. In addition to developing oral dexpramipexole for eosinophil-associated diseases, Knopp's preclinical Kv7 platform is directed to small molecule treatments for KCNQ2 epileptic encephalopathy, non-opioid treatments for pain, and other CNS hyperexcitability disorders. Please visit www.knoppbio.com.
REI Path Ahead Ventures is celebrating 16 emerging companies completing its Embark program, bringing the latest products and experiences to the outdoor industry. Embark is a three-month curriculum created in partnership with Founded Outdoors to...
BrainSell, the growth enablement company specializing in helping clients grow with top-of-the-line business technology solutions, has promoted Kevin Cook to Chief Technology Officer (CTO). Cook's 15 years at BrainSell, working across business...
Ferrilli, a leading provider of technology solutions for higher education institutions, proudly announces its recognition as the Ellucian Implementation Partner of the Year for 2023. This esteemed award marks the second consecutive year that Ferrilli...
A modified, upgraded, and perfectly preserved 2006 Pontiac GTO sponsored by CRC Industries will be auctioned May 15, 2024 with all proceeds going to TechForce Foundation, a nonprofit organization that funds education for and champions young people...
CareHive Health, a pioneer in data-driven, digital-first, white glove navigation solutions, proudly announces the appointment of Julianne Bride, MBA, as CareHive's Vice President of Strategic Partnerships and Client Success.
Julianne Bride's...
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of assays that predict and evaluate potential risks of...
